Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 30,464

Document Document Title
WO/2016/137832A1
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected w...  
WO/2016/135268A1
The invention relates to a method for preparing a chemical compound from a starting compound in a contaminant containing feedstock, wherein the feedstock comprises a contaminant, wherein the contaminant is selected from the group consist...  
WO/2016/135009A1
The invention relates to process for the preparation of gamma valerolactone (GVL) from levulinic acid (LA), said process comprising a) subjecting LA to a hydrogenation reaction comprising hydrogen and a solid catalyst system comprising a...  
WO/2016/135542A1
A process for the production of dipentyl ether from levulinic acid resulting from biomass including at least one polysaccharide comprising the following steps: (a) reacting said levulinic acid in the presence of hydrogen and at least one...  
WO/2016/137068A1
The present specification provides a hetero ring compound and an organic luminescent element comprising same.  
WO/2016/135070A1
The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6 and R7 are as described herein, compositions including the compounds and methods of using the compounds.  
WO/2016/133972A1
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV:  
WO/2016/131098A1
ABSTRACT The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in ...  
WO/2016/133970A1
Compounds of Formula (I), including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.  
WO/2016/133963A1
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and areuseful in treating those infected with HCV.  
WO/2016/133160A1
The purpose of the present invention is to provide a novel low molecular weight compound that exhibits orexin receptor agonist activity and is expected to be useful as an excellent preventative or therapeutic agent for narcolepsy or the ...  
WO/2016/134013A1
A diesel fuel and additive mixture is useful for reducing particulate matter emissions while improving or at least not aggravating oxidative stability during combustion. The additive includes at least one compound having a general formul...  
WO/2016/131821A1
The invention relates to a continuous or repetitive batch process for the hydrogenation of levulinic acid (LA) or esters thereof to at least gamma valerolactone (GVL) in a reactor comprising a feed stream and an outlet stream, in the pre...  
WO/2016/131521A1
The present invention relates to spirobifluorene derivatives of formula (I), the use thereof in electronic devices, and methods for producing said derivatives.  
WO/2016/133948A1
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV:  
WO/2016/131004A1
The integrated processes herein provide improved carbon efficiency for processes based on coal or biomass gasification or steam methane reforming. Provided are also ethylene oxide carbonylation products such as beta-propiolactone and suc...  
WO/2016/129819A1
The present invention relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. The organic electroluminescent compound according to the present invention can be comprised in a light-...  
WO/2016/129607A1
 An objective of the present invention is to provide a method for manufacturing a fluorine-containing cyclo olefin compound in which a compound having a fluorine atom bonded directly to each carbon forming a carbon-carbon double bond t...  
WO/2016/128044A1
A method for the reduction organic molecules comprising a Ruthenium-Triphosphine complex with aromatic ligands at the phosphors which are ortho or meta substituted.  
WO/2016/127874A1
Disclosed are a method for preparing an anticoagulant, and an intermediate and a preparation method therefor. Provided is a method for preparing an intermediate IV of vorapaxar sulfate, which comprises the following steps: in an organic ...  
WO/2016/126973A1
Disclosed herein are processes for forming 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-tetradecyloxy)furan-2-carboxylate:Formula (I)..  
WO/2016/125182A1
The present invention relates to compound of Formula (I) containing carbon-carbon linker, a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a prodrug, a polymorph, N -oxide, S-oxide, o...  
WO/2016/126975A1
Disclosed herein are processes for forming 2-furoic acid derivatives represented by Formula (I):.  
WO/2016/125782A1
As a chemically amplified resist, the present invention provides a resist and compound having a good balance by which line edge roughness (LER) is improved without impairing basic physical properties inherent in a resist, such as base ad...  
WO/2016/125871A1
Provided are a liquid crystal orientation agent enabling a liquid crystal display element having high response speed and excellent AC-derived afterimage characteristics, and a liquid crystal display element. The liquid crystal display el...  
WO/2016/124127A1
A photosensitive resin composition, containing ultraviolet photosensitive prepolymer resin, an active diluting monomer, an oxime ester photoinitiator represented by formula (I), and a colorant. The composition has good exposure sensibili...  
WO/2016/123361A1
An alternative approach to formation of a C-C bond at a meta-position of an aromatic compound is disclosed that employs an ethylenically unsaturated bicyclic compound as a transient mediator to achieve meta-selective C-H activation with ...  
WO/2016/119052A8
Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the cytotoxicity of virus to cells. Other uses, compositions and methods of usi...  
WO/2016/119052A1
Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the cytotoxicity of virus to cells. Other uses, compositions and methods of usi...  
WO/2016/123012A1
Provided herein are compounds of Formula (I), Formula (II), and Formula (III), and compositions comprising the same, as well as methods of use thereof for controlling or inhibiting the formation of calcium oxalate kidney stones, inhibiti...  
WO/2016/119051A1
Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus...  
WO/2016/123459A1
The present invention provides a method of making carboxylic acids from levulinic acid, such as succinic acid and 3-hydroxypropanoic acid, by reacting levulinic acid with an oxidant such as hydrogen peroxide under acidic or basic conditi...  
WO/2016/120879A1
The present invention provides compounds comprising fused tricyclic backbone structure and processes for their preparation. The invention further provides compounds and compositions useful in the treatment of pain and any type of disorde...  
WO/2016/117861A1
The present invention relates to a novel anthracene derivative, for an organic light-emitting device, and an organic light-emitting device comprising same, the anthracene derivative enabling excellent device characteristics when used as ...  
WO/2016/117848A1
The present invention relates to a compound, for an organic light-emitting device, enabling production of an organic light-emitting device by means of a low driving voltage, and an organic light-emitting device comprising same and, more ...  
WO/2016/113678A1
The invention relates to an improved process for the preparation of furfural from a xylose containing feedstock and more particularly to an elevated temperature conversion of a xylose containing feedstock to furfural in acidic conditions...  
WO/2016/113748A1
The invention relates to an improved process for the preparation of furfural from a xylose containing feedstock and more particularly to an elevated temperature conversion of a xylose containing feedstock to furfural in acidic conditions...  
WO/2016/114312A1
The purpose of the present invention is to provide a simple and efficient method for treating a tin compound in a reaction mixture. Provided is a method for carrying out a reaction, using stannous chloride, on a compound A as a raw mater...  
WO/2016/111347A1
Provided is a drug the active ingredient of which is a compound having antagonistic activity against EP4 receptor in the prevention and/or treatment of disease attributed to activation of EP4 receptor. The compound represented by general...  
WO/2016/112091A1
Electrochemical and photoelectrochemical cells for the oxidation of 5-hydroxymethylfurfural to 2,5-furandicarboxylic acid and/or 2,5-diformylfuran are provided. Also provided are methods of using the cells to carry out the electrochemica...  
WO/2016/112036A1
Methods for treating a tumor, such as a benign or malignant tumor, are disclosed herein. The methods include administering a therapeutically effective amount of a small molecule that selectively binds to and stabilizes G-quadruplex DNA i...  
WO/2016/110556A1
The invention relates to a method for producing tetrahydrofurane and/or 1,4-butanediol and/or gamma-butyrolactone, in particular a method for producing tetrahydrofurane (THF) from succinic acid, which can be obtained by converting biomas...  
WO/2016/112134A1
The present disclosure relates to systems, methods, and processes for the production of sugars and conversion products from biomass.  
WO/2016/109389A1
The present disclosure provides a process for the production of 4-azidosulfonylphthalic anhydride. In an embodiment, a process is provided and includes chlorinating 4-sulfophthalic acid trisodium salt (1), under solvent reaction conditio...  
WO/2016/105485A2
The present disclosure is directed to disclosed compounds that increase cystic fibrosis transmembrane conductance regulator (CFTR) activity as measured in human bronchial epithelial (hBE) cells.  
WO/2016/102426A1
Provided herein are flavor particles containing encapsulated precursors of acetylaldehyde. Also provided herein are methods of making and using the particles.  
WO/2016/102877A1
The invention relates to novel chemokine CXCR1 and CXCR2 receptor antagonist compounds of general formula (I), to pharmaceutical compositions containing said compounds, and to the use of said compounds and said compositions for the treat...  
WO/2016/106094A3
Methods of processing lignocellulose using metal-organic frameworks (MOFs) to form renewable platform chemicals that may be used as initial feedstock are provided. Metal -organic frameworks react with lignocellulosic derivatives such as ...  
WO/2016/105485A3
The present disclosure is directed to disclosed compounds that increase cystic fibrosis transmembrane conductance regulator (CFTR) activity as measured in human bronchial epithelial (hBE) cells.  
WO/2016/102428A1
Provided herein are formulations of plated powders of acetaldehyde precursors. Also provided herein are methods of making and using the powders.  

Matches 51 - 100 out of 30,464